Cargando…

Locoregional melanoma: identifying optimal care in a rapidly changing landscape

Detalles Bibliográficos
Autores principales:	Gyorki, David E, Zager, Jonathan S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891935/ https://www.ncbi.nlm.nih.gov/pubmed/31807273 http://dx.doi.org/10.2217/mmt-2019-0014

Ejemplares similares

Systemic therapies for unresectable locoregional melanoma: a significant area of need
por: Nan Tie, Emilia, et al.
Publicado: (2019)

Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress
por: DePalo, Danielle K., et al.
Publicado: (2023)

Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma
por: Tarhini, Ahmad, et al.
Publicado: (2018)

How we treat locoregional melanoma
por: Troiani, T., et al.
Publicado: (2021)

Men’s health: a rapidly changing landscape of healthcare delivery and treatment
por: Lipshultz, Larry I., et al.
Publicado: (2020)

Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
por: Zhang, Yuan, et al.
Publicado: (2019)

Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma
por: da Motta-Leal-Filho, Joaquim Maurício
Publicado: (2021)

The delicate balance of melanoma immunotherapy
por: Gyorki, David E, et al.
Publicado: (2013)

How Stereotactic Radiotherapy Changed the Landscape in Cancer Care
por: Kinj, Rémy, et al.
Publicado: (2023)

Changing landscapes
por: McCann, Shaun
Publicado: (2023)

A Changing Landscape
por: Doyle, Helen, et al.
Publicado: (2003)

A Changing Landscape
por: Neubacher, Saskia
Publicado: (2014)

Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape
por: Young, Shamar, et al.
Publicado: (2023)

Locoregional therapy in de novo metastatic breast cancer. The unanswered question
por: Cardoso, Maria-Joao, et al.
Publicado: (2021)

The neutrophil–lymphocyte ratio and locoregional melanoma: a multicentre cohort study
por: Robinson, Alyss V., et al.
Publicado: (2020)

The changing landscape of left ventricular assist device care in the setting of a pandemic
por: Amadio, Jennifer M., et al.
Publicado: (2020)

Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?
por: Guadagni, Stefano, et al.
Publicado: (2017)

The changing landscape of interventional cardiology
por: Jabbour, Richard J., et al.
Publicado: (2019)

Changing landscapes in cellular oncology
por: Geurts van Kessel, Ad
Publicado: (2012)

Journal publishing: the changing landscape
por: Satyanarayana, K.
Publicado: (2013)

The changing privacy landscape in the era of big data
por: Schadt, Eric E
Publicado: (2012)

Pediatric Research and COVID-19: the changed landscape
por: Molloy, E. J., et al.
Publicado: (2021)

Who Is to Blame for False-Negative Sentinel Node Biopsies in Melanoma?
por: Sondak, Vernon K., et al.
Publicado: (2009)

20/20 in 2020: seeking clarity on the management of stage III melanoma in a rapidly changing treatment environment
por: Chandrasekaran, Sanjay, et al.
Publicado: (2020)

Changing Invisible Landscapes – Financial Reform of Health and Care Systems: Ten Issues to Consider
por: Schroeder, Liz, et al.
Publicado: (2021)

The Changing Landscape of Healthcare and Continuing Education
por: Faiman, Beth
Publicado: (2020)

The changing landscape of scientific communication at EASD
por: Mathieu, Chantal, et al.
Publicado: (2022)

Journal subscriptions in the changing landscape: Are they needed?
por: Goel, Apul
Publicado: (2023)

Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage
por: Teterycz, Pawel, et al.
Publicado: (2019)

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020)

Next generation therapies change the landscape in melanoma
por: Flaherty, Keith T.
Publicado: (2011)

Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma
por: Broman, Kristy K, et al.
Publicado: (2019)

The emergence of neoadjuvant therapy in advanced melanoma
por: Sun, James, et al.
Publicado: (2019)

Treatment intensity in locoregionally advanced head and neck cancer: recent investigation leads to new questions
por: Bonner, James A., et al.
Publicado: (2019)

All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy
por: Kudo, Masatoshi
Publicado: (2023)

Is there still a role for the hepatic locoregional treatment of metastatic neuroendocrine tumors in the era of systemic targeted therapies?
por: Cavalcoli, Federica, et al.
Publicado: (2017)

Changing landscape of diagnosis and treatment of bladder cancer
por: Kim, Wun-Jae
Publicado: (2016)

The Changing Landscape of Respiratory Syncytial Virus Infections
por: Bem, Reinout A., et al.
Publicado: (2023)

Update on benefit of immunotherapy and targeted therapy in melanoma: the changing landscape
por: Srivastava, Neeharika, et al.
Publicado: (2014)

Locoregional therapy response in patients with hepatocellular cancer waiting for liver transplantation: Only selection or biological effect?
por: Lai, Quirino, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ffedtn6r59mfhnrprg26785u7l